About Pattern Pharma
Pattern Pharma is a company based in Toronto (Canada) founded in 2018. It operates as a HealthTech. Pattern Pharma has raised $7.66 million across 8 funding rounds. Pattern Pharma offers products and services including PPI-100. Pattern Pharma operates in a competitive market with competitors including Senti Biosciences, Caribou Biosciences, Immunocore, Autolus and Cargo Therapeutics, among others.
- Headquarter Toronto, Canada
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Pattern Pharma Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$7.66 M (USD)
in 8 rounds
-
Latest Funding Round
$798.49 K (USD), Series A
Apr 15, 2025
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Pattern Pharma
Pattern Pharma offers a comprehensive portfolio of products and services, including PPI-100. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
PPI-100 is developed as a TLR agonist therapeutic.
Funding Insights of Pattern Pharma
Pattern Pharma has successfully raised a total of $7.66M across 8 strategic funding rounds. The most recent funding activity was a Series A round of $798.49 thousand completed in April 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 8
- Last Round Series A — $798,485
-
First Round
First Round
(26 Nov 2018)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2025 | Amount | Series A - Pattern Pharma | Valuation |
investors |
|
| Feb, 2024 | Amount | Series A - Pattern Pharma | Valuation |
investors |
|
| May, 2021 | Amount | Series A - Pattern Pharma | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Pattern Pharma
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Pattern Pharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Pattern Pharma Comparisons
Competitors of Pattern Pharma
Pattern Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Senti Biosciences, Caribou Biosciences, Immunocore, Autolus and Cargo Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Cell-based therapies for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Provider of cell therapies to treat cancer and hematologic conditions
|
|
| domain | founded_year | HQ Location |
Developer of drugs based on T-Cell receptor technology for the treatment of cancer
|
|
| domain | founded_year | HQ Location |
Engineered T-cell immunotherapies are developed for cancer and auto-immune diseases.
|
|
| domain | founded_year | HQ Location |
Cell-based therapeutics for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
T-cell therapies targeting tumor neo-antigens for cancer are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Pattern Pharma
When was Pattern Pharma founded?
Pattern Pharma was founded in 2018.
Where is Pattern Pharma located?
Pattern Pharma is headquartered in Toronto, Canada. It is registered at Toronto, Ontario, Canada.
Is Pattern Pharma a funded company?
Pattern Pharma is a funded company, having raised a total of $7.66M across 8 funding rounds to date. The company's 1st funding round was a Series A of $4.15M, raised on Nov 26, 2018.
What does Pattern Pharma do?
Pattern Pharma is engaged in developing therapeutics that mobilize innate immunity to address immune failures in diseases, with a primary focus on cancer. The company targets the innate immune system as a frontline defense against infections and cancers, serving as a gateway to adaptive immunity. Its lead product, PPI-100, a TLR agonist, is being developed for perioperative use to reduce cancer relapse rates post-surgery. Solutions are aimed at solid tumors, which constitute a significant portion of cancer cases, by activating innate immune cells through receptor clustering. Research and clinical data support the potential of PPI-100 across various cancer applications, including monotherapy and combination therapies, as well as in infectious diseases and as a vaccine adjuvant. Collaborations with leading institutions further enhance development efforts in the healthcare sector.
Who are the top competitors of Pattern Pharma?
Pattern Pharma's top competitors include Immunocore, Achilles Therapeutics and Autolus.
What products or services does Pattern Pharma offer?
Pattern Pharma offers PPI-100.